Dr. Arash Karimi Afshar, DO

NPI: 1538778261
Total Payments
$744.10
2024 Payments
$488.59
Companies
7
Transactions
12

Payment Breakdown by Category

Food & Beverage$744.10 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $744.10 12 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $259.31 3 $0 (2024)
Amgen Inc. $235.86 3 $0 (2023)
Novo Nordisk Inc $121.81 1 $0 (2024)
Merck Sharp & Dohme LLC $56.02 2 $0 (2024)
Phathom Pharmaceuticals, Inc. $29.77 1 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $21.72 1 $0 (2024)
GlaxoSmithKline, LLC. $19.61 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $488.59 8 AstraZeneca Pharmaceuticals LP ($239.66)
2023 $255.51 4 Amgen Inc. ($235.86)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
07/24/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $21.72 General
Category: GI
07/23/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE Food and Beverage In-kind items and services $34.10 General
Category: VACCINE
07/11/2024 GlaxoSmithKline, LLC. AREXVY (Drug), SHINGRIX Food and Beverage In-kind items and services $19.61 General
Category: RESPIRATORY
05/30/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $119.83 General
Category: Respiratory
05/29/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $29.77 General
Category: GASTROENTEROLOGY
05/23/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $119.83 General
Category: Cardiovascular and Metabolism
02/28/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $121.81 General
02/13/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $21.92 General
Category: VACCINE
12/12/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $7.27 General
Category: Inflammation
11/02/2023 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $121.88 General
Category: Inflammation
10/12/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $106.71 General
Category: Cardiology
09/19/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $19.65 General
Category: Cardiovascular and Metabolism

About Dr. Arash Karimi Afshar, DO

Dr. Arash Karimi Afshar, DO is a Family Medicine healthcare provider based in Panorama City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2020. The National Provider Identifier (NPI) number assigned to this provider is 1538778261.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arash Karimi Afshar, DO has received a total of $744.10 in payments from pharmaceutical and medical device companies, with $488.59 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($744.10).

Practice Information

  • Specialty Family Medicine
  • Location Panorama City, CA
  • Active Since 07/28/2020
  • Last Updated 09/10/2024
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1538778261

Products in Payments

  • FARXIGA (Drug) $139.48
  • Otezla (Drug) $129.15
  • BREZTRI (Drug) $119.83
  • Repatha (Biological) $106.71
  • GARDASIL (Biological) $56.02
  • VOQUEZNA (Drug) $29.77
  • Linzess (Drug) $21.72
  • AREXVY (Drug) $19.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Panorama City